American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2017, 5(5), 113-115
DOI: 10.12691/ajmcr-5-5-2
Open AccessCase Report

Calciphylaxis Masquerading as Warfarin Induced Skin Necrosis

Nagadarshini Ramagiri Vinod1, Hassan Tahir1, , Saad Ullah1, Hassan Zeb1 and Arslan Ahmed2

1Temple University/Conemaugh Memorial Hospital Johnstown, PA, USA

2Social Security Hospital, Lahore, Pakistan

Pub. Date: May 27, 2017

Cite this paper:
Nagadarshini Ramagiri Vinod, Hassan Tahir, Saad Ullah, Hassan Zeb and Arslan Ahmed. Calciphylaxis Masquerading as Warfarin Induced Skin Necrosis. American Journal of Medical Case Reports. 2017; 5(5):113-115. doi: 10.12691/ajmcr-5-5-2

Abstract

Calciphylaxis is rare complication of end stage renal disease on hemodialysis. Calciphylaxis closely mimics warfarin induced skin necrosis in dialysis patients who are being started on coumadin thus posing a diagnostic challenge. Skin biopsy may be required in such cases to confirm the diagnosis.

Keywords:
warfarin skin necrosis caliphylaxis

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid:case report G Guerra, RC Shah, EA Ross - Nephrology Dialysis Transplantation, 2005 - ERA-EDTA.
 
[2]  Medline ® Abstract for Reference 32 of 'Calciphylaxis (calcific uremic arteriolopathy)'-Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A, Thadhani RI, Herzog CA.
 
[3]  Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Mazhar AR, Johnson RJ, Gillen D, Stivelman JC, Ryan MJ, Davis CL, Stehman-Breen CO.
 
[4]  Cutaneous necrosis from calcific uremic arteriolopathy. Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney AP.
 
[5]  Selye H, Gentile G, Pioreschi P: Cutaneous molt induced by calciphylaxis in the rat. Science134: 1876-1877,1961.
 
[6]  Budisavljevic MN, Cheek D, Ploth DW: Calciphylaxis in chronic renal failure.J Am Soc Nephrol7: 978-982, 1996.
 
[7]  Wallin R, Cain D, Sane DC: Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells: A cell system which resembles the system in bone cells. Thromb Haemost82 :1764-1767, 1999.
 
[8]  Brandenburg VM, Kramann R, Specht P, Ketteler M. Calciphylaxis in CKD and beyond. Nephrol Dial Transplant. 2012; 27: 1314-1318.
 
[9]  Hayden MR, Goldsmith D, Sowers JR, Khanna R. Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol. 2008; 40: 443-451.
 
[10]  Ng T, Tillyer ML. Warfarin-induced skin necrosis associated with Factor V Leiden and Protein S deficiency. Clin Lab Haematol 2001; 23: 261-4.
 
[11]  Comp PC, Elrod JP, Karzenski S. Warfarin-induced skin necrosis. Semin Thromb Hemost 1990; 16(4): 293-8.
 
[12]  Yatzidis H (1985) Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 23(2): 63-67.
 
[13]  Cicone JS, Petronis JB, Embert CD, Spector DA (2004) Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43(6): 1104-1108.
 
[14]  Geurra G, Shah RC, Ross AE (2005) Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant 20(6): 1260-1262.